Clinical Trial Update: Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers [Phase 1]

View source ↗

Summary

A completed Phase 1 randomized, placebo-controlled, unicentric interventional study evaluating the safety and potential effects of expanded allogeneic adipose-d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Tigenix S.A.U. | Conditions: Sepsis | Phase 1 | Status: COMPLETED